Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Separating the winners from the value traps is a tough challenge, and that’s where StockStory comes in. Our job is to find you high-quality companies that will stand the test of time. Keeping that in mind, here is one value stock trading at a big discount to its intrinsic value and two climbing an uphill battle.
Forward P/E Ratio: 13.2x
The first-ever Colombian company to trade on the NASDAQ, Tecnoglass (NYSE:TGLS) is a manufacturer of architectural glass, windows, and aluminum products.
Why Do We Think Twice About TGLS?
-
7.3% annual revenue growth over the last two years was slower than its industrials peers
-
Earnings per share have contracted by 3.2% annually over the last two years, a headwind for returns as stock prices often echo long-term EPS performance
-
Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 10.4 percentage points
Tecnoglass’s stock price of $51.17 implies a valuation ratio of 13.2x forward P/E. Check out our free in-depth research report to learn more about why TGLS doesn’t pass our bar.
Forward P/E Ratio: 13.5x
Founded in 1986 as a bridge between technology and financial services, SS&C Technologies (NASDAQ:SSNC) provides software and software-enabled services that help financial firms and healthcare organizations automate complex business processes.
Why Are We Wary of SSNC?
-
Efficiency has decreased over the last five years as its adjusted operating margin fell by 1.2 percentage points
-
Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 4.1 percentage points
-
Underwhelming 6.6% return on capital reflects management’s difficulties in finding profitable growth opportunities
SS&C is trading at $87.09 per share, or 13.5x forward P/E. To fully understand why you should be careful with SSNC, check out our full research report (it’s free for active Edge members).
Forward P/E Ratio: 12.9x
With a network spanning nine states and serving primarily urban and suburban communities, Tenet Healthcare (NYSE:THC) operates a nationwide network of hospitals, ambulatory surgery centers, and outpatient facilities providing acute care and specialty healthcare services.